Prevention of calcification in glutaraldehyde-treated porcine aortic and pulmonary valves

Annals of Thoracic Surgery

Volumn 64, Issue 4, 1997, Pages 1063-1066

  Chanda, Jyotirmay ^a   Kuribayashi, Ryosei ^a   Abe, Tadaaki ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTARALDEHYDE; HEPARIN;

ANIMAL CELL; ANIMAL TISSUE; AORTA VALVE DISEASE; ARTICLE; CALCIFICATION; CALCIUM DEFICIENCY; CONTROLLED STUDY; HISTOPATHOLOGY; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PULMONARY VALVE DISEASE; RAT; SWINE;

ANIMALS; BIOPROSTHESIS; CALCINOSIS; GLUTARAL; HEART VALVE PROSTHESIS; HEPARIN; MALE; PROSTHESIS FAILURE; RATS; RATS, WISTAR; SWINE;

EID: 0030689066     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(97)00819-9     Document Type: Article

References (25)

1. Monro JL, Salmon AP, Keeton BR. The outcome of antibiotic sterilised homografts used in Fontan procedure. Eur J Cardiothor Surg. 7:1993;360-364.
2. Cleveland DC, Williams WG, Razzouk AJ, et al. Failure of cryopreserved homograft valved conduits in the pulmonary circulation. Circulation. 86:(Suppl 2):1992;150-153.
3. Gallo R, Kumar N, Prabhakar G, Al-Halees Z, Duran CMG. Accelerated degeneration of aortic homograft in an infant. J Thorac Cardiovasc Surg. 107:1994;1161-1162.
4. Clarke DR, Campbell DN, Hayward AR, Bishop DA. Degeneration of aortic valve allografts in young recipients. J Thorac Cardiovasc Surg. 105:1993;934-942.
5. Yankah AC, Wottge HU, Müller-Hermelink HK, et al. Transplantation of aortic and pulmonary allografts, enhanced viability of endothelial cells by cryopreservation. Importance of histocompatibility. J Card Surg. 1:(Suppl):1987;209-220.
6. Burdon TA, Miller DC, Oyer PE, et al. Durability of porcine valves at fifteen years in a representative North American patient population. J Thorac Cardiovasc Surg. 103:1992;238-252.
7. Jamieson WRE, Rosudo LJ, Munro AI, et al. Carpentier-Edwards standard porcine bioprosthesis primary tissue failure (structural valve deterioration) by age groups . Ann Thorac Surg. 46:1988;155-162.
8. Fann JI, Miller DC, Moore KA, et al. Twenty-year clinical experience with porcine bioprostheses. Ann Thorac Surg. 62:1996;1301-1312.
9. Christie GW, Barratt-Boyes BG. Mechanical properties of pulmonary valve leaflets how do they differ from aortic leaflets? Ann Thorac Surg. 60:1995;S195-S199.
10. Christie GW. The anatomy of aortic heart valve leaflets the influence of glutaraldehyde fixation on function . Eur J Cardiothorac Surg. 6:(Suppl 1):1992;S23-S33.
11. Christie GW, Barratt-Boyes BG. Identification of a failure mode of the antibiotic sterilized aortic allograft after 10 years implications for their long-term survival . J Cardiac Surg. 6:1991;462-467.
12. Barratt-Boyes BG, Christie GW, Raudkivi PJ. The stentless bioprosthesis surgical challenges and implications for long-term durability . Eur J Cardiothorac Surg. 6:(Suppl 1):1992;S39-S43.
13. David H, Boughner D, Vesely I, Gerosa G. The pulmonary valve is it mechanically suitable for use as an aortic valve replacement . ASAIO J. 40:1994;206-212.
14. Leeson-Dietrich J, Boughner D, Vesely I. Porcine pulmonary and aortic valves a comparison of their tensile viscoelastic properties at physiologic strain rates . J Heart Valve Dis. 4:1995;88-94.
15. Gerosa G, Ross DN, Brucke PE, et al. Aortic valve replacement with pulmonary homografts early experiences . J Thorac Cardiovasc Surg. 107:1994;424-437.
16. Caplice NM, West MJ, Campbell GR, Campbell J. Inhibition of human vascular smooth muscle cell growth by heparin. Lancet. 344:1994;97-98.
17. Hiebert LM, Jaques L. The observation of heparin on endothelium after injection. Thromb Res. 8:1976;195-204.
18. Villanueva G, Danishefsky I. Evidence for a heparin-induced conformational change of antithrombin III. Biochem Biophys Res Commun. 74:1977;803-809.
19. Norman M, Norrby K. Tumor cell volume changes in vivo induced by heparin. Pathol Eur. 6:1971;268-277.
20. Ragazzi E, Chinellato A. Heparin pharmacological potentials from atherosclerosis to asthma . Gen Pharmacol. 26:1995;697-701.
21. Kanabrocki EL, Sothern RB, Bremner WF, et al. Heparin as a therapy for atherosclerosis preliminary observations on the intrapulmonary administration of low-dose heparin in the morning versus evening gauged by its effect on blood variables . Chronobiol Int. 8:1991;210-233.
22. Shulman AG. Heparin and atherosclerosis an investigative report on the treatment of atherosclerosis . Biomed Pharmacother. 44:1990;303-306.
23. Chanda J. Anticalcification treatment of pericardial prostheses. Biomaterials. 15:1994;465-469.
24. Chanda J, Rao SB, Mohanty M, et al. Calcification prevention of tissue valve. Artif Organs. 18:1994;752-757.
25. Chanda J. Prevention of calcification of heart valve bioprostheses an experimental study in rat . Ann Thorac Surg. 60:1995;S339-S342.